New genetic research has identified a direct causal chain connecting the microorganisms in the human digestive tract to the ...

Loot box regulation intensifies globally as researchers and regulators warn of gambling-like risks, weak disclosures, and ...

Ocular Therapeutix Inc. (NASDAQ:OCUL) is a biopharmaceutical company that develops and commercializes therapies for retinal ...

H-2B program is used by American companies to hire foreign nationals for temporary non-agricultural occupations in the United ...

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Approval was based on the phase 3 ENERGIZE and ENERGIZE-T studies evaluating the safety and efficacy of mitapivat in adults with alpha- or beta-thalassemia.

Exercise improves quality of life and sleep in ovarian cancer patients, with moderate and significant benefits, respectively. Methodological variability and high heterogeneity in trials highlight the ...

Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.

Data included more than a million participants to find that Alzheimer's risk was up to 76% lower in these cases.

The United States is revamping its H-1B visa lottery system, prioritizing high-skilled, high-paid workers over a random ...

Clinical trials continue to shape metastatic breast cancer treatment, making therapies safer, more tolerable, and more ...

New York State Psychiatric Institute and Columbia University Medical Center investigators, with co-authors across additional ...